Task: Answer the multiple-choice question.
Query: Which drug exhibits a 5.044% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a. CCn1c(NN)nc2sc3c(c2c1=O)CCC3
b. CC1(C)CC(=O)C2=C(C1)c1c(ccc3ccccc13)NC2c1ccco1
c. COc1cccc(C(=O)C2CN(c3ccccc3)CC2c2ccc(Cl)cc2)c1
Answer: c. COc1cccc(C(=O)C2CN(c3ccccc3)CC2c2ccc(Cl)cc2)c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1cccc(C(=O)C2CN(c3ccccc3)CC2c2ccc(Cl)cc2)c1
COc1cccc(C(=O)C2CN(c3ccccc3)CC2c2ccc(Cl)cc2)c1
[4-(4-chlorophenyl)-1-phenylpyrrolidin-3-yl]-(3-methoxyphenyl)methanone